Yamashita, A. S., da Costa Rosa, M., Stumpo, V., Rais, R., Slusher, B. S., & Riggins, G. J. (2020). The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling. Neurooncol Adv.
Chicago Style aipamenaYamashita, Alex Shimura, Marina da Costa Rosa, Vittorio Stumpo, Rana Rais, Barbara S. Slusher, and Gregory J. Riggins. "The Glutamine Antagonist Prodrug JHU-083 Slows Malignant Glioma Growth and Disrupts MTOR Signaling." Neurooncol Adv 2020.
MLA aipamenaYamashita, Alex Shimura, et al. "The Glutamine Antagonist Prodrug JHU-083 Slows Malignant Glioma Growth and Disrupts MTOR Signaling." Neurooncol Adv 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.